A small Emeryville, CA biotech firm is developing InvisiMask, a self-administered nasal spray, that protects against SARS-CoV-2 infection, the novel coronavirus that causes COVID-19, for up to 10 hours in early animal studies. The hope would be to...
Just over 24 hours after an FDA advisory panel recommended emergency use of Pfizer and BioNTech’s COVID-19 vaccine, the agency followed through, authorizing the first coronavirus pandemic shot for emergency use in the U.S.
The FDA...
Late day Thursday, a government advisory panel gave their nods for the use of Pfizer’s COVID-19 vaccine, allowing for the Food and Drug Administration (FDA) to grant the approval for the vaccine.
In a 17-4...
In a published study, in EBio Medicine, researchers at Arizona-based biotech, Aqualung Therapeutics may have identified a novel biomarker that alone, or potentially combined with Prostate-specific antigen (PSA), may determine men who are at higher risk of...
The US Food and Drug Administration on Friday evening granted Emergency Use Authorization for the first time to a diagnostic test for at-home, self-collection of patient samples for the detection of SARS-CoV-2 and influenza A/B.
According to new research published today in the American Heart Association's flagship journal Circulation, women face a 20% increased risk of developing heart failure or dying within five years after their first severe heart attack compared with...
Moderna today announced that the primary efficacy analysis of their Phase 3 study of their vaccine candidate, mRNA-1273 conducted on 196 cases confirms the high efficacy observed at the first interim analysis. The data analysis indicates a...
Northwestern University researchers have developed a new artificial intelligence (A.I.) platform that detects COVID-19 by analyzing X-ray images of the lungs.
Called DeepCOVID-XR, the machine-learning algorithm outperformed a team of specialized thoracic radiologists --...
A third COVID-19 vaccine, this one from AstraZeneca, reported Monday that late-stage trials showed that its COVID-19 vaccine with Oxford University was up to 90% effective in preventing disease.
The results are based on...
Pfizer Inc. and its German partner, BioNTech SE will submit a request today to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of their mRNA vaccine candidate, BNT162b2 against SARS-CoV-2, which will potentially enable...
The Prix Galien Awards Committee announced that six world-leading biopharma companies responsible for the development of COVID-19 vaccines and therapeutics will jointly...
According to media reports, the Food and Drug Administration is pushing to approve Pfizer-BioNTech’s two-dose Covid-19 vaccine by early next week, further...
The WWE will create non-fungible-tokens (NFTs) inspired by WWE Superstar John Cena, along with never-before-sold memorabilia and experiences, just in time for...
